Personal tools

MCL coexpression mm9:2312: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002193!1.40e-14!48;UBERON:0002405!1.40e-14!48;UBERON:0002390!6.95e-13!45;UBERON:0003061!6.95e-13!45;UBERON:0000077!3.21e-12!35;UBERON:0004177!3.46e-12!29;UBERON:0005057!3.46e-12!29;UBERON:0003408!1.06e-09!24;UBERON:0002370!2.35e-09!23;UBERON:0000974!2.35e-09!23;UBERON:0004807!2.35e-09!23;UBERON:0005058!2.35e-09!23;UBERON:0003351!2.35e-09!23;UBERON:0009113!2.35e-09!23;UBERON:0003295!2.35e-09!23;UBERON:0009722!2.35e-09!23;UBERON:0005562!2.35e-09!23;UBERON:0007690!2.35e-09!23;UBERON:0006562!1.46e-08!24;UBERON:0001557!1.46e-08!24;UBERON:0001042!1.46e-08!24;UBERON:0008814!1.46e-08!24;UBERON:0009145!1.46e-08!24;UBERON:0005911!4.45e-08!69;UBERON:0002530!1.20e-07!65;UBERON:0003929!1.78e-07!55;UBERON:0001041!2.84e-07!80;UBERON:0001007!3.91e-07!116;UBERON:0001555!3.91e-07!116;UBERON:0007026!3.91e-07!116;UBERON:0001004!4.76e-07!42;UBERON:0002368!4.78e-07!60;UBERON:0004119!5.27e-07!118;UBERON:0000925!5.27e-07!118;UBERON:0006595!5.27e-07!118;UBERON:0000065!9.64e-07!41
|ontology_enrichment_uberon=UBERON:0002193!1.40e-14!48;UBERON:0002405!1.40e-14!48;UBERON:0002390!6.95e-13!45;UBERON:0003061!6.95e-13!45;UBERON:0000077!3.21e-12!35;UBERON:0004177!3.46e-12!29;UBERON:0005057!3.46e-12!29;UBERON:0003408!1.06e-09!24;UBERON:0002370!2.35e-09!23;UBERON:0000974!2.35e-09!23;UBERON:0004807!2.35e-09!23;UBERON:0005058!2.35e-09!23;UBERON:0003351!2.35e-09!23;UBERON:0009113!2.35e-09!23;UBERON:0003295!2.35e-09!23;UBERON:0009722!2.35e-09!23;UBERON:0005562!2.35e-09!23;UBERON:0007690!2.35e-09!23;UBERON:0006562!1.46e-08!24;UBERON:0001557!1.46e-08!24;UBERON:0001042!1.46e-08!24;UBERON:0008814!1.46e-08!24;UBERON:0009145!1.46e-08!24;UBERON:0005911!4.45e-08!69;UBERON:0002530!1.20e-07!65;UBERON:0003929!1.78e-07!55;UBERON:0001041!2.84e-07!80;UBERON:0001007!3.91e-07!116;UBERON:0001555!3.91e-07!116;UBERON:0007026!3.91e-07!116;UBERON:0001004!4.76e-07!42;UBERON:0002368!4.78e-07!60;UBERON:0004119!5.27e-07!118;UBERON:0000925!5.27e-07!118;UBERON:0006595!5.27e-07!118;UBERON:0000065!9.64e-07!41
|tfbs_overrepresentation_for_novel_motifs=0.641384,0.128156,0.612053,0.688265,1.21364,0.704257,0.803568,0.370124,0.381467,0.489964,0.755749,0.790506,0.96877,0.81685,0.502646,0,1.02248,0.473993,0.352304,0.24402,0.570433,0.57409,0.815872,0.481455,0.620553,0.846564,0.342316,0.727368,0.535752,0.290745,0.711848,1.12823,0.471365,0.318879,0.503207,0.089443,0.460474,0.786577,0.434783,0.40068,0.478558,0.717547,0.544696,0.504971,0.0986756,0.675898,0.938241,0.744678,0.49007,1.3327,1.0041,0.875451,0.282443,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,1.02399,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.98374,0.205546,1.32691,0.323563,0.310084,0.318792,0.926147,1.08947,0.575233,0.37865,1.04072,0.884013,0.951203,1.20828,0.11855,0.40635,0.791209,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,0.430015,0.409166,0.367176,1.14445,0.938512,0.264911,0.460566,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,0.580757,0.57247,0.633483,1.25851,0.576517,0.7614,1.51002,0.476467,0.869142,0.692434,1.02384,0.456123,1.33244,0.970073,0.848526,0.925183,1.56496,1.09333,0.812403,1.13449,1.43038,0.493609,1.23918,0.680176,1.40022,1.9576,1.53196,1.70121,0.650785,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.79777,0.184289,1.27621,0.416214,0.838313,1.35996,0.87653,0.516549,0.63863,2.65007,1.49167,1.20739,1.09379,0.630949,0.993294,0.830321,0.459159,0.788782,0.280875
}}
}}

Revision as of 21:13, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr1:52065508..52065522,+p2@Stat4
Mm9::chr1:52065530..52065548,+p3@Stat4
Mm9::chr4:129488887..129488928,+p@chr4:129488887..129488928
+
Mm9::chr9:44413427..44413454,-p@chr9:44413427..44413454
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
hemolymphoid system1.40e-1448
immune system1.40e-1448
hematopoietic system6.95e-1345
blood island6.95e-1345
mixed endoderm/mesoderm-derived structure3.21e-1235
hemopoietic organ3.46e-1229
immune organ3.46e-1229
gland of gut1.06e-0924
thymus2.35e-0923
neck2.35e-0923
respiratory system epithelium2.35e-0923
hemolymphoid system gland2.35e-0923
pharyngeal epithelium2.35e-0923
thymic region2.35e-0923
pharyngeal gland2.35e-0923
entire pharyngeal arch endoderm2.35e-0923
thymus primordium2.35e-0923
early pharyngeal endoderm2.35e-0923
pharynx1.46e-0824
upper respiratory tract1.46e-0824
chordate pharynx1.46e-0824
pharyngeal arch system1.46e-0824
pharyngeal region of foregut1.46e-0824
endo-epithelium4.45e-0869
gland1.20e-0765
gut epithelium1.78e-0755
foregut2.84e-0780
digestive system3.91e-07116
digestive tract3.91e-07116
primitive gut3.91e-07116
respiratory system4.76e-0742
endocrine gland4.78e-0760
endoderm-derived structure5.27e-07118
endoderm5.27e-07118
presumptive endoderm5.27e-07118
respiratory tract9.64e-0741


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}